Consistent with the stimulatory effect of CaMK2 on drug resistance in human colon cancer, an experiment on hypopharyngeal carcinoma (HPC) reported that the mRNA level of CaMK2α was increased when FaDu cells were treated with TPF. Here, CAMK2B is linked to malignant colon neoplasm.